Retrospective assessment of islet cell autoantibodies in pancreas organ donors

Autor: George W. Burke, Joseph M. Ferreira, Gloria Allende, Alberto Pugliese, Stavros Diamantopoulos, Gaetano Ciancio
Rok vydání: 2008
Předmět:
medicine.medical_specialty
Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
Insulin Antibodies
030209 endocrinology & metabolism
030230 surgery
Pancreas transplantation
Gastroenterology
ABO Blood-Group System
03 medical and health sciences
Islets of Langerhans
0302 clinical medicine
Pancreatectomy
Internal medicine
Diabetes mellitus
Internal Medicine
medicine
Cadaver
Humans
Kidney transplantation
Autoantibodies
Retrospective Studies
Advanced and Specialized Nursing
Type 1 diabetes
business.industry
Glutamate Decarboxylase
Autoantibody
Clinical Care/Education/Nutrition/Psychosocial Research
Immunosuppression
medicine.disease
Kidney Transplantation
Tissue Donors
3. Good health
medicine.anatomical_structure
Diabetes Mellitus
Type 1

Immunology
Pancreas Transplantation
Pancreas
business
Zdroj: Diabetes Care
ISSN: 1935-5548
Popis: OBJECTIVE—Of deceased pancreas donors, 3–4% may have autoantibodies (AAb) to pancreatic islet cell antigens; these autoantibodies are well-established markers of type 1 diabetes. We investigated whether donor AAb positivity could affect the outcome of pancreas transplantation. RESEARCH DESIGN AND METHODS—We retrospectively tested AAb in 135 donors whose pancreata and kidneys were transplanted in type 1 diabetes patients. We measured AAb to glutamic acid decarboxylase (GAD-AAb), the tyrosine-phosphatase-like protein IA2 (IA2-AAb), and insulin (insulin-AAb). We then evaluated pancreas transplant outcome data. RESULTS—Four of 135 (2.96%) donors were AAb positive: three donors had GAD-AAb, and one donor had insulin-AAb. Their respective recipients became insulin independent on follow-up. Three of the four recipients had normal, insulin-producing grafts 3–5.8 years after transplant. The recipient of the insulin-AAb–positive donor pancreas developed chronic rejection following discontinuation of immunosuppression 3.3 years after transplant. CONCLUSIONS—Single AAb positivity did not affect the outcome of pancreas transplantation in our study.
Databáze: OpenAIRE